Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vita Brawley
Autologous HER2 CMV Bispecific CAR T Cells Are Safe and Demonstrate Clinical Benefit for Glioblastoma in a Phase I Trial.
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Anti-Car-Engineered T Cells for Epitope-Based Elimination of Autologous CAR T Cells
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Targeting Glioblastoma With CAR T Cells
Cancer Discovery
Oncology
Automated Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells at an Academic Center for a Phase I Clinical Trial in Relapsed, Refractory NHL
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Tandem CAR T Cells Targeting HER2 and IL13Rα2 Mitigate Tumor Antigen Escape
Journal of Clinical Investigation
Medicine
A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Clinical Cancer Research
Cancer Research
Oncology
